In situ transitional cell carcinoma involvement of prostatic urethra: Bacillus calmette-guérin therapy without previous transurethral resection of the prostate

Urology

Volumn 47, Issue 4, 1996, Pages 482-484

  Palou, J ^a,b   Xavier, B ^a   Laguna, P ^a   Montlleo M ^a   Vicente, J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Department of Urology ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URETHRA FUNCTION;

ADMINISTRATION, INTRAVESICAL; AGED; BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; TREATMENT OUTCOME; URETHRAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0029885379     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80481-6     Document Type: Article

References (19)

1. Ortega LG, Whitmore FR Jr, and Murphy AI: In situ carcinoma of the prostate with intra-epithelial extension into the urethra and bladder. Cancer 6: 898-923, 1953.
2. Matzkin H, Soloway MS, and Handerman S: Transitional cell carcinoma of the prostate. J Urol 146: 1207-1212, 1991.
3. Thelmo WL, Seemayer TA, Madarnas P, Mount BM, and Mackinnon KJ: Carcinoma in situ of the bladder with associated prostatic involvement. J Urol 111: 491-494, 1974.
4. Seemayer TA, Knaack J, Thelmo WL, Wang NS, and Ahmed NM: Further observations on carcinoma in situ of the urinary bladder: silent but extensive intraprostatic involvement. Cancer 36: 514-520, 1975.
5. Schellhammer PF, Bean MA, and Whitmore WF Jr: Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J Urol 118: 399-403, 1977.
6. Morales A, Eldinger D, and Bruce AW: Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 116: 180-183, 1976.
7. Herr HW: Carcinoma in situ of the bladder. Semin Urol 1: 15-22, 1983.
8. Lamm DL: Bacillus Calmette-Guérin immunotherapy in bladder cancer. J Urol 134: 40-47, 1985.
9. de Kernion JB, Huang MY, Linanfr A, Smith RB, and Kaufman JJ: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guérin. J Urol 133: 598-601, 1985.
10. Bretton PR, Herr HW, Whitmore WF Jr, Badalament RA, Kimmel M, Provet J, Oettgen HF, Melamed MR, and Fair WR: Intravesical bacillus Calmette-Guérin therapy for in situ transitional cell carcinoma involving the prostatic urethra. J Urol 141: 853-856, 1989.
11. Hillyard RW Jr, Ladaga L, and Schellhammer PF: Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guérin. J Urol 139: 290-293, 1988.
12. Friedell GH, Soloway MS, Hilgar AG, and Farrow GM: Summary of workshop on carcinoma in situ of the bladder. J Urol 136: 1047-1048, 1986.
13. Kirk D, Hinton CE, and Shaldon C: Transitional cell carcinoma of the prostate. Br J Urol 51: 575-578, 1979.
14. Chibber PJ, McIntrye MA, Hindmarsh JR, Hargreave JB, Newsam JF, and Chisholm GD: Transitional cell carcinoma involving the prostate. Br J Urol 53: 605-609, 1981.
15. Hardeman SW, and Soloway MS: Transitional cell carcinoma of the prostate: diagnosis, staging and management. World J Urol 6: 170-174, 1988.
16. Lamm DL, Stogdill UD, Stogdill BJ, and Crispen RG: Complications of bacillus Calmette-Guérin immunotherapy in 1278 patients with bladder cancer. J Urol 135: 272-274, 1986.
17. Droller MJ: Bacillus Calmette-Guérin in the management of bladder cancer. J Urol 135: 331-333, 1986.
18. Schellhammer PF, Ladaga LE, and Moriarty RP: Intravesical bacillus Calmette-Guérin for treatment of superficial transitional cell carcinoma of prostatic urethra in association with carcinoma of the bladder. J Urol 153: 53-56, 1995.
19. Ovesen H, Poulsen AL, and Steven K: Intravesical bacillus Calmette-Guérin with the Danish strain for the treatment of carcinoma in situ of the bladder. Br J Urol 72: 744-748, 1993.